Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group.
about
A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers13th Annual Congress of the European Society of Intensive Care Medicine, Rome, Italy, 1-4 October 2000Blood management in intensive care medicine: CRIT and ABC--what can we learn?Artificial Blood Substitutes: First Steps on the Long Route to Clinical UtilityFluid resuscitation from severe hemorrhagic shock using diaspirin cross-linked hemoglobin fails to improve pancreatic and renal perfusionComparison of transfusion with DCLHb or pRBCs for treatment of intraoperative anemia in sheepEffect of diaspirin cross-linked haemoglobin (DCLHb) on mean arterial pressure during cardiopulmonary bypass in swineDCL-Hb for trauma patients with severe hemorrhagic shock: the European "On-Scene" multicenter studyThe clinical trials of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock: the tale of two continentsArtificial oxygen carriers as red blood cell substitutes: a selected review and current statusHemodynamic and Hematologic Effects of Histotripsy of Free-Flowing Blood: Implications for Ultrasound-Mediated ThrombolysisErythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injuryHemoglobin Vesicles prolong the time to circulatory collapse in rats during apneaBiophysical Properties of Lumbricus terrestris Erythrocruorin and Its Potential Use as a Red Blood Cell SubstituteHemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.Resuscitation fluids.Biophysical properties and oxygenation potential of high-molecular-weight glutaraldehyde-polymerized human hemoglobins maintained in the tense and relaxed quaternary states.Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines.Anemia and red blood cell transfusion in neurocritical care.Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers.Bio-inspired nanomedicine strategies for artificial blood components.Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients.Extracellular Methemoglobin Mediated Early ROS Spike Triggers Osmotic Fragility and RBC Destruction: An Insight into the Enhanced Hemolysis During Malaria.Hemoglobin mediated contraction of the isolated rat thoracic aorta: why is precontraction necessary?Hemoglobin solutions: use in surgical patients.A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and Pentastarch.Comparison of PEG-modified albumin and hemoglobin in extreme hemodilution in the rat.Expectations and implications of blood sparing with hemoglobin based oxygen carriers.
P2860
Q24650633-0372F43C-2094-4E25-BE2B-BDA328A0D1F8Q24795810-59D1A3E6-FD5F-4E2C-BB65-49BE3A38FD16Q24805702-84078CF0-0623-45B9-9AC2-C7AEF70D8EDCQ28075789-0C71A1EA-7DF7-451C-B802-A5BB485D4159Q28171289-B3BE5049-514B-4371-AC10-E3ADE56D6924Q28191883-D47479AB-5911-4ABF-98F7-3DFDE1984B28Q28193954-9E89144D-9A48-42B5-A5E3-EE35CB9CCFA8Q28194704-84038301-C678-4064-B329-B211287604A3Q28195741-256E56CF-2CC2-4B89-B9C4-A7DE0B0C719FQ28277962-E7FE5000-8A15-4914-8032-66FFE7C2E047Q30373340-AE7226E8-3D8A-4D76-8B31-DD780BB0A504Q30487336-398C5409-1415-44A2-BC9A-E9AD41C38919Q30841757-BEA6F2B2-49E7-46FE-B6AF-C9CECED15D6DQ33649878-61AA5E03-0847-43DB-95E0-54B213929BA2Q34133584-B9AB1635-102E-497A-9988-F9D3FA7A6E91Q34539441-6FBD52EA-645D-4560-B0DF-EF2486489C4CQ34715341-68ED31FD-7A80-4807-9C0E-D61C83CE9F3EQ36780187-4C746121-FEB0-4DA8-A88B-8038212161E2Q36941158-6FA4E5A7-46A2-4219-AE9C-AE8C8AA22142Q37279874-9ED1F551-FB42-4F68-BF73-C445AA149787Q37727980-B19C0189-5E0B-4556-9C21-606A4E1FBE02Q39179984-170ADA8C-F82F-4A24-8401-B4E5DE36104CQ42111692-32C4886F-C2AE-4247-8BD2-27435F731D53Q42176393-27800F5F-9FA5-4932-88ED-00E72160A4FFQ42475581-517C6A55-E342-4763-B384-8C73D22B83CDQ45836600-972E39FD-4B70-455A-90F3-1A70B838D7EFQ46990325-E3992F20-EDC5-417B-B933-873F98757842Q47316496-B0D2CE48-8584-4D1C-AC32-3CAE95B134DBQ51919745-22BA7ACD-A7BE-4785-A58F-E29A22473E81
P2860
Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Randomized trial of diaspirin ...... ery Trial Collaborative Group.
@en
Randomized trial of diaspirin ...... ery Trial Collaborative Group.
@nl
type
label
Randomized trial of diaspirin ...... ery Trial Collaborative Group.
@en
Randomized trial of diaspirin ...... ery Trial Collaborative Group.
@nl
prefLabel
Randomized trial of diaspirin ...... ery Trial Collaborative Group.
@en
Randomized trial of diaspirin ...... ery Trial Collaborative Group.
@nl
P2093
P1433
P1476
Randomized trial of diaspirin ...... ery Trial Collaborative Group.
@en
P2093
Berridge JC
Brichant JF
Demeyere RH
Larbuisson RP
Parsloe MR
Przybelski RJ
P304
P356
10.1097/00000542-200003000-00007
P407
P577
2000-03-01T00:00:00Z